HSBC/CALL/CENTENE/80/0.1/16.01.26 Stock

Warrant

DE000HS5RPY1

Market Closed - Börse Stuttgart 04:39:36 2024-07-03 EDT
0.68 EUR +9.68% Intraday chart for HSBC/CALL/CENTENE/80/0.1/16.01.26
Current month-5.56%
1 month-27.66%
Date Price Change
24-07-03 0.68 +9.68%
24-07-02 0.62 -8.82%
24-07-01 0.68 -5.56%
24-06-28 0.72 -1.37%
24-06-27 0.73 +1.39%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 04:39 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CENTENE CORPORATION
Issuer HSBC
WKN HS5RPY
ISINDE000HS5RPY1
Date issued 2024-03-28
Strike 80 $
Maturity 2026-01-16 (562 Days)
Parity 10 : 1
Emission price 1.42
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.43
Lowest since issue 0.62
Delta0.48x
Omega 4.042
Premium31.63x
Gearing8.48x
Moneyness 0.8345
Difference Strike 13.24 $
Difference Strike %+16.55%
Spread 0.04
Spread %5.33%
Theoretical value 0.7300
Implied Volatility 32.14 %
Total Loss Probability 67.62 %
Intrinsic value 0.000000
Present value 0.7300
Break even 87.87 €
Theta-0.01x
Vega0.03x
Rho0.03x

Company Profile

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
-
More about the company

Ratings for Centene Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Centene Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
66.76 USD
Average target price
87.52 USD
Spread / Average Target
+31.09%
Consensus